ArticleScientific reports2025
Elucidating the synergistic role of hybrid peptide from Burkholderia cepacia enzymes in biodegradation of polycyclic aromatic hydrocarbons.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- In Silico Approach for Fluorene Biodegradation, and the Impacts of Derivatives on the Environment and Health.Journal of xenobiotics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polycyclic aromatic hydrocarbons (PAHs) are hazardous environmental contaminants emerging from industrial activities and fossil fuel combustion, posing risks to human health and ecosystems. Biodegradation offers a sustainable approach to mitigating PAH pollution, and here we investigated the efficacy of a peptide hybrid of laccase and O-methyltransferase enzymes from the bacterium Burkholderia cepacia in PAH degradation. Both enzymes demonstrated stability with an instability index below 40, indicating suitability for environmental application. Following active site prediction, the 3D structure of the peptide hybrid, consisting of 71 amino acids, was modelled using trRosetta, achieving a high-quality structure with an ERRAT score above 97%. Further bioinformatic analysis confirmed the hybrid's non-allergenic and non-virulent properties. Molecular docking studies revealed a robust binding affinity above - 9 kcal/mol, highlighting this peptide hybrid's potential for effective PAH degradation and suggesting its promise as an eco-friendly bioremediation agent for PAH-contaminated sites.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.